121 related articles for article (PubMed ID: 12454377)
1. Blood viscosity and platelet function in patients with obstructive sleep apnea syndrome treated with nasal continuous positive airway pressure.
Reinhart WH; Oswald J; Walter R; Kuhn M
Clin Hemorheol Microcirc; 2002; 27(3-4):201-7. PubMed ID: 12454377
[TBL] [Abstract][Full Text] [Related]
2. Nasal continuous positive airway pressure treatment reduces systemic oxidative stress in patients with severe obstructive sleep apnea syndrome.
Christou K; Kostikas K; Pastaka C; Tanou K; Antoniadou I; Gourgoulianis KI
Sleep Med; 2009 Jan; 10(1):87-94. PubMed ID: 18077211
[TBL] [Abstract][Full Text] [Related]
3. Impact of nasal continuous positive airway pressure therapy on markers of platelet activation in patients with obstructive sleep apnea.
Akinnusi ME; Paasch LL; Szarpa KR; Wallace PK; El Solh AA
Respiration; 2009; 77(1):25-31. PubMed ID: 18812691
[TBL] [Abstract][Full Text] [Related]
4. Evidence for lipid peroxidation in obstructive sleep apnea.
Lavie L; Vishnevsky A; Lavie P
Sleep; 2004 Feb; 27(1):123-8. PubMed ID: 14998248
[TBL] [Abstract][Full Text] [Related]
5. Effect of continuous positive airway pressure treatment on elderly Chinese patients with obstructive sleep apnea in the prethrombotic state.
Zhang X; Yin K; Wang H; Su M; Yang Y
Chin Med J (Engl); 2003 Sep; 116(9):1426-8. PubMed ID: 14527381
[TBL] [Abstract][Full Text] [Related]
6. Short-term continuous positive airway pressure therapy reverses the pathological influence of obstructive sleep apnea on blood rheology parameters.
Tazbirek M; Slowinska L; Skoczynski S; Pierzchala W
Clin Hemorheol Microcirc; 2009; 41(4):241-9. PubMed ID: 19318717
[TBL] [Abstract][Full Text] [Related]
7. Falls in blood pressure in patients with obstructive sleep apnoea after long-term nasal continuous positive airway pressure treatment.
Chin K; Nakamura T; Takahashi K; Sumi K; Matsumoto H; Niimi A; Fukuhara S; Mishima M; Nakamura T
J Hypertens; 2006 Oct; 24(10):2091-9. PubMed ID: 16957571
[TBL] [Abstract][Full Text] [Related]
8. Erythrocyte deformability, plasma viscosity and oxidative status in patients with severe obstructive sleep apnea syndrome.
Dikmenoğlu N; Ciftçi B; Ileri E; Güven SF; Seringeç N; Aksoy Y; Ercil D
Sleep Med; 2006 Apr; 7(3):255-61. PubMed ID: 16564211
[TBL] [Abstract][Full Text] [Related]
9. Effect of continuous positive airway pressure therapy on hypothalamic-pituitary-adrenal axis function and 24-h blood pressure profile in obese men with obstructive sleep apnea syndrome.
Carneiro G; Togeiro SM; Hayashi LF; Ribeiro-Filho FF; Ribeiro AB; Tufik S; Zanella MT
Am J Physiol Endocrinol Metab; 2008 Aug; 295(2):E380-4. PubMed ID: 18523125
[TBL] [Abstract][Full Text] [Related]
10. Morning increase of whole blood viscosity in obstructive sleep apnea syndrome.
Nobili L; Schiavi G; Bozano E; De Carli F; Ferrillo F; Nobili F
Clin Hemorheol Microcirc; 2000; 22(1):21-7. PubMed ID: 10711818
[TBL] [Abstract][Full Text] [Related]
11. Effects of NCPAP therapy on fibrinogen levels in obstructive sleep apnea syndrome.
Chin K; Ohi M; Kita H; Noguchi T; Otsuka N; Tsuboi T; Mishima M; Kuno K
Am J Respir Crit Care Med; 1996 Jun; 153(6 Pt 1):1972-6. PubMed ID: 8665063
[TBL] [Abstract][Full Text] [Related]
12. Evening and morning blood gases in patients with obstructive sleep apnea.
Guardiola J; Yu J; Hasan N; Fletcher EC
Sleep Med; 2004 Sep; 5(5):489-93. PubMed ID: 15341895
[TBL] [Abstract][Full Text] [Related]
13. Altered blood rheology in obstructive sleep apnea as a mediator of cardiovascular risk.
Steiner S; Jax T; Evers S; Hennersdorf M; Schwalen A; Strauer BE
Cardiology; 2005; 104(2):92-6. PubMed ID: 16015032
[TBL] [Abstract][Full Text] [Related]
14. Serum amyloid a in obstructive sleep apnea.
Svatikova A; Wolk R; Shamsuzzaman AS; Kara T; Olson EJ; Somers VK
Circulation; 2003 Sep; 108(12):1451-4. PubMed ID: 12952844
[TBL] [Abstract][Full Text] [Related]
15. Mouth breathing in obstructive sleep apnea prior to and during nasal continuous positive airway pressure.
Ruhle KH; Nilius G
Respiration; 2008; 76(1):40-5. PubMed ID: 18042974
[TBL] [Abstract][Full Text] [Related]
16. Effect of nCPAP therapy on heart rate in patients with obstructive sleep apnoea-hypopnoea.
Sumi K; Chin K; Takahashi K; Nakamura T; Matsumoto H; Niimi A; Mishima M
QJM; 2006 Aug; 99(8):545-53. PubMed ID: 16861714
[TBL] [Abstract][Full Text] [Related]
17. Effects of armodafinil in the treatment of residual excessive sleepiness associated with obstructive sleep apnea/hypopnea syndrome: a 12-week, multicenter, double-blind, randomized, placebo-controlled study in nCPAP-adherent adults.
Roth T; White D; Schmidt-Nowara W; Wesnes KA; Niebler G; Arora S; Black J
Clin Ther; 2006 May; 28(5):689-706. PubMed ID: 16861091
[TBL] [Abstract][Full Text] [Related]
18. [Effects of nasal continuous positive airway pressure on serum leptin concentration and the metabolic parameters in obstructive sleep apnea hypopnea syndrome].
Huang R; Huang XZ; Wang HG; Li M; Xiao Y
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Apr; 26(2):168-71. PubMed ID: 15171555
[TBL] [Abstract][Full Text] [Related]
19. Adherence to nCPAP in patients with coronary disease and sleep apnea without sleepiness.
Sampol G; Rodés G; Romero O; Jurado MJ; Lloberes P
Respir Med; 2007 Mar; 101(3):461-6. PubMed ID: 16919928
[TBL] [Abstract][Full Text] [Related]
20. [Significance of the changes of platelet activation and fibrinolytic activity in patients with obstructive sleep apnea-hypopnea syndrome].
Feng H; Feng H; Zhang C; Wu K; Yuan Y; Yang H; Guan J; Wang B
Zhonghua Jie He He Hu Xi Za Zhi; 2002 Sep; 25(9):531-4. PubMed ID: 12423560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
